Article

ANTIC_Oxcarbazepine

Anticonvulstants

Related Videos
John J. Miller, MD
John J. Miller, MD
John J. Miller, MD
John J. Miller, MD
John J. Miller, MD
John J. Miller, MD
Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA
Related Content
research
October 14th 2024

TEV-'749: An Option to Serve an Important Treatment Gap for Patients With Schizophrenia

Christoph U. Correll, MD
Collaborative Approach to Treatment-Resistant Depression Management: A Q&A With Michael Asbach, DMSc, PA-C
May 14th 2024

Collaborative Approach to Treatment-Resistant Depression Management: A Q&A With Michael Asbach, DMSc, PA-C

Sponsored by Johnson & Johnson
brain
October 14th 2024

Will Denial Make DSM’s Validity Problem Go Away? A Reply to Pies and Ruffalo

Jussi Valtonen, PhD Jani Kajanoja, MD, PhD
Lifestyle Interventions for ADHD
May 4th 2022

Lifestyle Interventions for ADHD

research
October 11th 2024

Uzedy: Reducing the Risk of Relapse in Patients With Schizophrenia

Christoph U. Correll, MD
PTSD
October 11th 2024

Complex PTSD: A Necessary DSM Addition

John J. Miller, MD
© 2024 MJH Life Sciences

All rights reserved.